Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Memory engram stability and flexibility
    Published on 2024-09-18
    10 months ago
  • The anxiogenic drug yohimbine is a reinforcer in male and female rats
    Published on 2024-09-17
    10 months ago
  • In Memoriam: Burton M. Angrist, MD
    Published on 2024-09-17
    10 months ago
  • PET imaging in rat brain shows opposite effects of acute and chronic alcohol exposure on phosphodiesterase-4B, an indirect biomarker of cAMP activity
    Published on 2024-09-16
    10 months ago
  • A covert cortical ensemble for learned fear suppression
    Published on 2024-09-16
    10 months ago
  • Reframing addiction: It’s not the destination, but the journey
    Published on 2024-09-16
    10 months ago
  • The might of light for revealing neuropsychiatric mechanisms
    Published on 2024-09-12
    10 months ago
« Previous 1 … 24 25 26 27 28 … 143 Next »
Journal of Psychopharmacology
  • Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial
    Published on 2024-03-23
    1 year ago
  • Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I
    Published on 2024-03-18
    1 year ago
  • Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II
    Published on 2024-03-18
    1 year ago
  • A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature
    Published on 2024-03-18
    1 year ago
  • Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study
    Published on 2024-03-18
    1 year ago
  • Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use
    Published on 2024-03-14
    1 year ago
  • Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression
    Published on 2024-03-13
    1 year ago
« Previous 1 … 24 25 26 27 28 … 123 Next »
European Neuropsychopharmacology
  • Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials
    Published on 2024-04-21
    1 year ago
  • Schizophrenia patients are not benefiting from worldwide improvements in life expectancy
    Published on 2024-04-21
    1 year ago
  • Cognitive screening in bipolar disorder
    Published on 2024-04-21
    1 year ago
  • Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
    Published on 2024-04-21
    1 year ago
  • Pre-existing chronic physical morbidity and excess mortality in people with bipolar disorder: A population-based cohort study in 2008–2018
    Published on 2024-04-21
    1 year ago
  • Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis
    Published on 2024-04-20
    1 year ago
  • Prescribing therapeutic apps within National Health Services: The critical role of evaluation and monitoring
    Published on 2024-04-20
    1 year ago
« Previous 1 … 24 25 26 27 28 … 144 Next »

   Pharma Pub